Neuronal expression of myeloperoxidase is increased in Alzheimer's disease

被引:284
作者
Green, PS
Mendez, AJ
Jacob, JS
Crowley, JR
Growdon, W
Hyman, BT
Heinecke, JW
机构
[1] Univ Washington, Dept Med, Div Gerontol, Seattle, WA 98195 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[4] Univ Miami, Sch Med, Dept Med, Miami, FL USA
关键词
Alzheimer's disease; 3-chlorotyrosine; myeloperoxidase; oxidative stress; o; '-dityrosine;
D O I
10.1111/j.1471-4159.2004.02527.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myeloperoxidase, a heme protein expressed by professional phagocytic cells, generates an array of oxidants which are proposed to contribute to tissue damage during inflammation. We now report that enzymatically active myeloperoxidase and its characteristic amino acid oxidation products are present in human brain. Further, expression of myeloperoxidase is increased in brain tissue showing Alzheimer's neuropathology. Consistent with expression in phagocytic cells, myeloperoxidase immunoreactivity was present in some activated microglia in Alzheimer brains. However, the majority of immunoreactive material in brain localized with amyloid plaques and, surprisingly, neurons including granule and pyramidal neurons of the hippocampus. Confirming neuronal localization of the enzyme, several neuronal cell lines as well as primary neuronal cultures expressed myeloperoxidase protein. Myeloperoxidase mRNA was also detected in neuronal cell lines. These results reveal the unexpected presence of myeloperoxidase in neurons. The increase in neuronal myeloperoxidase expression we observed in Alzheimer disease brains raises the possibility that the enzyme contributes to the oxidative stress implicated in the pathogenesis of the neurodegenerative disorder.
引用
收藏
页码:724 / 733
页数:10
相关论文
共 66 条
[1]   The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins:: a mechanism for producing advances glycation end products at sites of inflammation [J].
Anderson, MM ;
Requena, JR ;
Crowley, JR ;
Thorpe, SR ;
Heinecke, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) :103-113
[2]   Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein - A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation [J].
Anderson, MM ;
Hazen, SL ;
Hsu, FF ;
Heinecke, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (03) :424-432
[3]   QUANTITATIVE-DETERMINATION OF MYELOPEROXIDASE USING TETRAMETHYLBENZIDINE AS SUBSTRATE [J].
ANDREWS, PC ;
KRINSKY, NI .
ANALYTICAL BIOCHEMISTRY, 1982, 127 (02) :346-350
[4]   Mitochondria, free radicals, and neurodegeneration [J].
Beal, MF .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (05) :661-666
[5]  
BEAL MF, 1994, NEUROBIOL AGING, V15, P171
[6]   Novel neural modulators [J].
Boehning, D ;
Snyder, SH .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :105-131
[7]   INVERSE ASSOCIATION OF ANTIINFLAMMATORY TREATMENTS AND ALZHEIMERS-DISEASE - INITIAL RESULTS OF A COTWIN CONTROL STUDY [J].
BREITNER, JCS ;
GAU, BA ;
WELSH, KA ;
PLASSMAN, BL ;
MCDONALD, WM ;
HELMS, MJ ;
ANTHONY, JC .
NEUROLOGY, 1994, 44 (02) :227-232
[8]   The metallobiology of Alzheimer's disease [J].
Bush, AI .
TRENDS IN NEUROSCIENCES, 2003, 26 (04) :207-214
[9]   Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide [J].
Butterfield, DA ;
Drake, J ;
Pocernich, C ;
Castegna, A .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (12) :548-554
[10]   8-nitro-2′-deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase hydrogen peroxide nitrite system of activated human phagocytes [J].
Byun, J ;
Henderson, JP ;
Mueller, DM ;
Heinecke, JW .
BIOCHEMISTRY, 1999, 38 (08) :2590-2600